Sana Biotechnology Stock

Sana Biotechnology Liabilities 2024

Sana Biotechnology Liabilities

277.79 M USD

Ticker

SANA

ISIN

US7995661045

In 2024, Sana Biotechnology's total liabilities amounted to 277.79 M USD, a -14.1% difference from the 323.4 M USD total liabilities in the previous year.

Sana Biotechnology Aktienanalyse

What does Sana Biotechnology do?

Sana Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Sana Biotechnology's Liabilities

Sana Biotechnology's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sana Biotechnology's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Sana Biotechnology's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Sana Biotechnology's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Sana Biotechnology’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Sana Biotechnology stock

What is the level of liabilities of Sana Biotechnology this year?

Sana Biotechnology has a debt balance of 277.79 M USD this year.

What were the liabilities of Sana Biotechnology compared to the previous year?

The liabilities of Sana Biotechnology have increased by -14.1% dropped compared to the previous year.

What are the consequences of high debt for investors of Sana Biotechnology?

High liabilities can pose a risk for investors of Sana Biotechnology, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Sana Biotechnology?

Low liabilities mean that Sana Biotechnology has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Sana Biotechnology affect the company?

An increase in liabilities of Sana Biotechnology can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Sana Biotechnology affect the company?

A decrease in the liabilities of Sana Biotechnology can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Sana Biotechnology?

Some factors that can influence the liabilities of Sana Biotechnology include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Sana Biotechnology so important for investors?

The liabilities of Sana Biotechnology are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Sana Biotechnology take to modify the liabilities?

To change its liabilities, Sana Biotechnology can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Sana Biotechnology pay?

Over the past 12 months, Sana Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sana Biotechnology is expected to pay a dividend of 0 USD.

What is the dividend yield of Sana Biotechnology?

The current dividend yield of Sana Biotechnology is .

When does Sana Biotechnology pay dividends?

Sana Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sana Biotechnology?

Sana Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Sana Biotechnology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sana Biotechnology located?

Sana Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sana Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sana Biotechnology from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Sana Biotechnology pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Sana Biotechnology in the year 2023?

In the year 2023, Sana Biotechnology distributed 0 USD as dividends.

In which currency does Sana Biotechnology pay out the dividend?

The dividends of Sana Biotechnology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sana Biotechnology

Our stock analysis for Sana Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sana Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.